Scolaris Content Display Scolaris Content Display

Sequencing of anthracyclines and taxanes in neoadjuvant and adjuvant therapy for early breast cancer

This is not the most recent version

Appendices

Appendix 1. CENTRAL

#1 MeSH descriptor: [Breast Neoplasms] explode all trees
#2 (breast near cancer*):ti,ab,kw
#3 (breast near neoplasm*):ti,ab,kw
#4 (breast near carcinoma*):ti,ab,kw
#5 (breast near tumour*):ti,ab,kw
#6 (breast near tumor*):ti,ab,kw
#7 #1 or #2 or #3 or #4 or #5 or #6
#8 MeSH descriptor: [Anthracyclines] explode all trees
#9 (anthracycline* or doxorubicin or epirubicin or daunorubicin or idarubicin or valrubicin):ti,ab,kw
#10 #8 or #9
#11 MeSH descriptor: [Taxoids] explode all trees
#12 (taxane* or docetaxel or paclitaxel or nab‐paclitaxel or Cabazitaxel):ti,ab,kw
#13 #11 or #12
#14 #7 and #10 and #13

Appendix 2. MEDLINE

1

exp Anthracyclines/

2

anthracycline$.tw.

3

doxorubicin.tw.

4

epirubicin.tw.

5

daunorubicin.tw.

6

idarubicin.tw.

7

valrubicin.tw.

8

or/1‐7

9

exp Taxoids/

10

taxane$.tw.

11

docetaxel.tw.

12

paclitaxel.tw.

13

nab‐paclitaxel.tw.

14

Cabazitaxel.tw.

15

or/9‐14

16

8 and 15

17

randomized controlled trial.pt.

18

controlled clinical trial.pt.

19

randomized.ab.

20

placebo.ab.

21

Clinical Trials as Topic/

22

randomly.ab.

23

trial.ti.

24

(crossover or cross‐over).tw.

25

Pragmatic Clinical Trials as Topic/

26

pragmatic clinical trial.pt.

27

or/17‐26

28

exp Breast Neoplasms/

29

(breast adj6 cancer$).tw.

30

(breast adj6 neoplasm$).tw.

31

(breast adj6 carcinoma$).tw.

32

(breast adj6 tumo?r$).tw.

33

or/28‐32

34

16 and 27 and 33

35

remove duplicates from 34

36

Animals/ not Humans/

37

35 not 36

Appendix 3. Embase

1

Randomized controlled trial/

2

Controlled clinical study/

3

Random$.ti,ab.

4

randomization/

5

intermethod comparison/

6

placebo.ti,ab.

7

(compare or compared or comparison).ti.

8

(open adj label).ti,ab.

9

((double or single or doubly or singly) adj (blind or blinded or blindly)).ti,ab.

10

double blind procedure/

11

parallel group$1.ti,ab.

12

(crossover or cross over).ti,ab.

13

((assign$ or match or matched or allocation) adj5 (alternate or group$1 or intervention$1 or patient$1 or subject$1 or participant$1)).ti,ab.

14

(assigned or allocated).ti,ab.

15

(controlled adj7 (study or design or trial)).ti,ab.

16

(volunteer or volunteers).ti,ab.

17

trial.ti.

18

or/1‐17

19

exp breast/

20

exp breast disease/

21

(19 or 20) and exp neoplasm/

22

exp breast tumor/

23

exp breast cancer/

24

exp breast carcinoma/

25

(breast$ adj5 (neoplas$ or cancer$ or carcin$ or tumo$ or metasta$ or malig$)).ti,ab.

26

or/21‐25

27

exp anthracycline/

28

anthracycline$.tw.

29

exp doxorubicin/

30

doxorubicin.tw.

31

exp epirubicin/

32

epirubicin.tw.

33

exp daunorubicin/

34

daunorubicin.tw.

35

exp idarubicin/

36

idarubicin.tw.

37

exp valrubicin/

38

valrubicin.tw.

39

or/27‐38

40

exp taxoid/

41

taxane derivative/

42

taxane$.tw.

43

exp docetaxel/

44

docetaxel.tw.

45

exp paclitaxel/

46

paclitaxel.tw.

47

nab‐paclitaxel.tw.

48

exp cabazitaxel/

49

Cabazitaxel.tw.

50

or/40‐49

51

18 and 26 and 39 and 50

52

limit 51 to (human and embase)

Appendix 4. WHO ICTRP

Basic search:

Breast cancer AND Anthracycline AND Taxane

Advanced search:

Condition: Breast cancer

Intervention: (doxorubicin OR epirubicin OR daunorubicin OR idarubicin OR valrubicin) AND (docetaxel OR paclitaxel OR nab‐paclitaxel OR Cabazitaxel)

Recruitment status: ALL

Appendix 5. ClinicalTrials.gov

1. Condition/disease: Breast cancer

Intervention/treatment: Anthracyclines AND Taxanes

Filters: Interventional

2. Condition/disease: Breast cancer

Intervention/treatment: (doxorubicin OR epirubicin OR daunorubicin OR idarubicin OR valrubicin) AND (docetaxel OR paclitaxel OR nab‐paclitaxel OR Cabazitaxel)

Filters: Interventional